The Leadership Team at Ascidian Therapeutics is responsible for setting the strategic vision, overseeing the company's clinical and operational activities, ensuring financial health, guiding scientific research, and managing program development. This cohesive group of high-level executives collaborates to drive the company’s mission of advancing gene therapy solutions to treat challenging diseases, thereby enabling treatment for millions of patients worldwide.
Alia Rashid
Vice President, Clinical Devel...
Carmen Jacome
Vice President, Program Manage...
Carrie Wager
Svp, Head Of Operations
Daniel Rosan
CFO and CBO
Michael Ehlers
Founder, President, And Chief ...
Robert Bell
Chief Scientific Officer
Sarah DiSalvatore, M...
Vice President Clinical Operat...
Sarah Fashena
Vp, Intellectual Property Stra...
View all